C9062 is a valid 2023 HCPCS Code that could be used to indicate Injection, daratumumab 10 mg and hyaluronidase-fihj for reimbursement purposes.
C9062 belongs to Other Medical Items or Services Type of Service and has been in effect since Jan 01, 2021.
Daratumumab hyaluronidase
C9062 code information
| HCPCS code: | C9062 |
| Description: | INJECTION, DARATUMUMAB 10 MG AND HYALURONIDASE-FIHJ |
| Effective Date: | Jan 01, 2021 |
| Added Date: | Oct 01, 2020 |
| Termination Date: | HCPCS C9062 was terminated on Dec 31, 2020 |
| Pricing indicator: | 53 - STATUTE |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | D - SPECIAL COVERAGE INSTRUCTIONS APPLY |
| BETOS code: | O1D - CHEMOTHERAPY |
| Action code: | D - DISCONTINUE PROCEDURE OR MODIFIER CODE |
| Type of Service: |
9 - OTHER MEDICAL ITEMS OR SERVICES
F - AMBULATORY SURGICAL CENTER (FACILITY USAGE FOR SURGICAL SERVICES)
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to C9062